Why Brand Saridon clicks with all despite competition and a brief ban

Every second, 21 consumers in India pop a Saridon to relieve themselves of a pounding headache. In ten years, Saridon, whose brand licensing rights were picked up by Piramal Enterprises in the 1990s from pharma major Roche, has grown 20 times. It now has a turnover of Rs 100 crore from Rs 5 crore a decade ago and accounts for a fourth of the Piramal group’s revenue within its consumer products division. Plans are afoot to grow its retail presence aggressively  in addition to launching a host of new variants in the future.   For a humble headache pill, developed by Roche in Sw.....
Key stories on business-standard.com are available to premium subscribers only.

Already a premium subscriber?

Subscribe to get an across device (Website, Mobile Web, Iphone, Ipad, and Android Phone applications) access to Premium content, Breaking News alerts, Industry Newsletters, Stock and Corporate news alerts, access to Archives and a lot more.